Abstract
The utility of self-determination theory in predicting adherence to antiviral therapy (ART) was investigated in 205 HIV+ (85% male) patients. Participants completed brief structured adherence interviews and measures of perceived autonomy support, autonomous motivation, and perceived competence, specific to ART. Adherence measures included percentage of doses administered and precision of dose scheduling. As hypothesized, greater autonomy support predicted greater autonomous motivation for adherence, which predicted adherence through an indirect relationship mediated by perceived competence. Autonomy support from health care providers was most predictive of autonomous motivation. Psychological distress also contributed to the variance in adherence. Study results demonstrate the importance of psychological factors in predicting ART adherence, and emphasize the role of internal motivations and competencies.
Similar content being viewed by others
REFERENCES
Arbuckle, J. H. (1989). AMOS: Analysis of moment structures. American Statistician, 43, 66.
Bakken, S., Holzemer, W. L., Brown, M. A., Powell-Cope, G. M., Turner, J. G., Inouve, J., et al. (2000). Relationships between perception of engagement with health care provider and demographic char-acteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care and STDs, 14(4), 189-197.
Bandura, A. (1977). Perceived competence: Toward a unifying theory of behavioral change. Psychological Review, 84, 191-215.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adhernce to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
Becker, S., Dezil, C. M., Burtcel, B., Kawabata, H., & Hodder, S. (2002). Young HIV-infected adults are at greater risk for medication nonadherence. Medscape HIV/AIDS eJournal, 8(4). Retrieved February 27, 2004, from http://www.medscape.com/viewarticle/438510.
Cameron, D. W., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., et al. (1998). Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet, 351, 543-549.
Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed newtreatments for HIV disease. Health Psychology, 19(2), 124-133.
Chesney, M. A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
Dunbar-Jacob, J., Burke, L. E., & Puczynski, S. (1995). Clinical assessment and management of adherence to medical regimens. In P. M. Nicassio & T. W. Smith (Eds.), Managing chronic illness. Washington, DC: American Psychological Association.
Friedland, G. H., & Williams, A. (1999). Attaining higher goals in HIV treatment: The central importance of adherence. AIDS, 13, 61-72.
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123-126.
Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., & Smith, D. K. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIVpatients' understanding of their. regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes, 28(2), 124-131.
Holzemer, W. L., Henry, S. B., Nokes, K. M., Corless, I. B., Brown, M., Powell-Cope, G. M., et al. (1999). Validation of the sign and symptom checklist for persons with HIV disease (SSC-HIV). Journal of Advanced Nursing, 30, 1041-1049.
Kastrissios, H., Suarex, J. R., Katzenstein, D., Girard, P., Sheiner, L. B., & Blaschke, T. F. (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS, 12, 2295-2303.
Kelly, J. A., Otto-Salaj, L. L., Sikkema, K. J., Pinkerton, S. D., & Bloom, F. R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310-319.
Lyketsos, C. G., & Treisman, G. J. (2001). Mood disorders in HIV infection. Psychiatric Annals, 31(1), 45-49.
Maggiolo, F., Ripamonti, D., Arici, C., Gregis, G., Quinzan, G., Camacho, G. A., et al. (2002). Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clinical Trials, 5(5), 371-378.
Magura, S., Laudet, A. B., Mahmood, D., Rosenblum, A., & Knight, E. (2002). Adherence to medication regimens and participation in dual focus self-help groups. Psychiatric Services, 53(3), 310-6.
McNair, D., Lorr, M., & Droppleman, L. (1971). Profile of mood states. San Diego: EdITS/Educational and Industrial Testing Service.
Mehta, S., Moore, R. D., & Graham, N. M. H. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., & Lau, T. F. J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD and AIDS, 13(5), 301-310.
Nieuwkerk, P. T., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). ATHENA Project. Limited patient adherence to highly active antiviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine, 161(16), 1962-1968.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
Rabkin, J. G., & Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In D. G. Ostrow & S. C. Kalichman (Eds.), Psychosocial and Public Health Impacts of New HIV Therapies(pp. 61-82). NY: Plenum Publisher.
Roberts, K. J., & Mann, T. (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12(4), 377-386.
Ryan, R. M., Plant, R. W., & O'Malley, S. (1995). Initial motivations for alcohol treatment: Relations with patient characteristics, treatment, involvement, and dropout. Addictive Behaviors, 20, 279-297.
Saag, M. S., Tebas, P., Sension, M., Conant, M., Myers, R., Chapman, S. K., et al. (2002). Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). AIDS, 15, 1971-1978.
Safren, S. A., Otto, Michael, W., Worth, J. L., Salomon, E., Johnson, W., et al. (2001). Two strategies to in-crease adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research & Therapy, 39(10), 1151-1162.
Sikkema, K., & Kelly, J. A. (1996). Behavioral medicine interventions can improve the quality of life and health of persons with HIV disease. Annals of Behavioral Medicine, 18(1), 40-48.
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., et al. (1999). Efavirenz plus zidovudine and lamivudine, evarienz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. New England Journal of Medicine, 341, 1865-1873.
Swindells, S., Mohr, J., Justis, J. C., Berman, S., Squier, C., Wagener, M. M., et al. (1999). Quality of life in patients with human immunodeficiency virus infection: Impact of social support, coping style, and hopelessness. International Journal of STD and AIDS, 10, 383-391.
Tuldra, A., Fumaz, C., Ferrer, M., Bayes, R., Arno, A., Balague, M., et al. (2000). Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 25(3), 221-228.
Williams, G. C., Cox, E. M., Kouides, R., & Deci, E. L. (1999). Presenting the facts about smoking to adolescents: The effects of an autonomy supportive style. Archives of Pediatrics and Adolescent Medicine, 153, 959-964.
Williams, G. C., Deci, E. L., & Ryan, R. M. (1998). Supporting patients' autonomy to promote maintained behavior change and positive health outcomes. In A. L. Suchman, R. Botelho, & P. Hinton-Walker (Eds.), Partnerships, power, and process: Transforming health care delivery(pp. 67-87). Rochester, NY: University of Rochester Press.
Williams, G. C., Frankel, R. M., Campbell, T. L., & Deci, E. L. (2000). Research on relationship-centered care and healthcare outcomes from the Rochester Biopsychosocial Program: A Self-Determination Theory integration. Families, Systems, and Health, 18(1), 79-90.
Williams, G. C., Freedman, Z. R., & Deci, E. L. (1998). Supporting autonomy to motivate glucose control in patients with diabetes. Diabetes Care, 21, 1644-1651.
Williams, G. C., Gagne, M., Ryan, R. M., & Deci, E. L. (2002). Facilitating autonomous motivation for smoking cessation. Health Psychology, 21(1), 40-50.
Williams, G. C., Grow, V. M., Freedman, Z., Ryan, R. M., & Deci, E. L. (1996). Motivational predictors of weight loss and weight-loss maintenance. Journal of Personality and Social Psychology, 70, 115-126.
Williams, G. C., Rodin, G. C., Ryan, R. M., & Grolnick, W. S. (1998). Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychology, 17(3), 269-276.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kennedy, S., Goggin, K. & Nollen, N. Adherence to HIV Medications: Utility of the Theory of Self-Determination. Cognitive Therapy and Research 28, 611–628 (2004). https://doi.org/10.1023/B:COTR.0000045568.95219.e2
Issue Date:
DOI: https://doi.org/10.1023/B:COTR.0000045568.95219.e2